Studies from our group have used the highly aggressive EGFR-dependent human epidermoid carcinoma A431 cells (four million EGFR receptors per cell; Hsieh et al, 2010) as an in vitro platform to assess the role of EGFR ligands on the functioning and efficacy of Ctx in SCC. The gene discussed is EGFR; the disease is squamous cell carcinoma.